NCT00376233View on ClinicalTrials.gov

Niacin Flushing as Marker of Cannabis Effects on Arachidonic Acid Pathways in Schizophrenia

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

February 29, 2004

Study Completion Date

June 30, 2005

Conditions
SchizophreniaCannabis Abuse
Trial Locations (1)

D-07743

University of Jena, Department of Psychiatry, Jena

All Listed Sponsors
lead

University of Jena

OTHER

NCT00376233 - Niacin Flushing as Marker of Cannabis Effects on Arachidonic Acid Pathways in Schizophrenia | Biotech Hunter | Biotech Hunter